COMPLETEDN/A

Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019

This study will determine the outcomes of anatomic lung resections in patients who recovered from coronavirus disease 2019 (COVID-19) disease by describing the morbidity and mortality as well as the length of postoperative hospital stay.

Sponsor

Lung Center of the Philippines

Enrollment

16 participants

Sites

1 locations

Start Date

October 2022

Completion

October 2022

COVID-19Lung CancerLung TBHemoptysisanatomic lung resection

Enrollment & Timeline

Completed

Target N

participants

Sites

locations

Duration

1 months

total trial span

Rate

pts/month needed

At 1 sites, each site needs to enroll approximately 16.0 patients/month to hit the enrollment target on schedule.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Pulmonary Lobectomy After COVID-19.

Testori Alberto, Perroni Gianluca, Voulaz Emanuele et al.The Annals of thoracic surgery2021

DOI PubMed

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.

Anaesthesia2021

DOI PubMed

Elective lung resection after treatment for COVID-19 pneumonia.

Sakai Takashi, Azuma Yoko, Aoki Kotaro et al.General thoracic and cardiovascular surgery2021

DOI PubMed

Lobectomy with pathological examination in lung cancer patients who recovered from COVID-19.

Nefedov Andrey, Mortada Makhmud, Novitskaya Tatyana et al.General thoracic and cardiovascular surgery2021

DOI PubMed

Pulmonary Parenchymal Changes in COVID-19 Survivors.

Diaz Ashley, Bujnowski Daniel, McMullen Phillip et al.The Annals of thoracic surgery2022

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

COMPLETEDN/A

Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019

Sponsor

Lung Center of the Philippines

Enrollment

16 participants

Sites

1 locations

Start Date

October 2022

Completion

October 2022

COVID-19Lung CancerLung TBHemoptysisanatomic lung resection

Enrollment & Timeline

Completed

Target N

participants

Sites

locations

Duration

1 months

total trial span

Rate

pts/month needed

At 1 sites, each site needs to enroll approximately 16.0 patients/month to hit the enrollment target on schedule.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Pulmonary Lobectomy After COVID-19.

Testori Alberto, Perroni Gianluca, Voulaz Emanuele et al.The Annals of thoracic surgery2021

DOI PubMed

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.

Anaesthesia2021

DOI PubMed

Elective lung resection after treatment for COVID-19 pneumonia.

Sakai Takashi, Azuma Yoko, Aoki Kotaro et al.General thoracic and cardiovascular surgery2021

DOI PubMed

Lobectomy with pathological examination in lung cancer patients who recovered from COVID-19.

Nefedov Andrey, Mortada Makhmud, Novitskaya Tatyana et al.General thoracic and cardiovascular surgery2021

DOI PubMed

Pulmonary Parenchymal Changes in COVID-19 Survivors.

Diaz Ashley, Bujnowski Daniel, McMullen Phillip et al.The Annals of thoracic surgery2022

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Mortality rate

perioperative period (up to 30 days after anatomic lung resection)

proportion of patients who died due to perioperative complications

Major complication rate

perioperative period (up to 30 days after anatomic lung resection)

proportion of patients who develop acute kidney injury, acute myocardial infarction, acute respiratory distress syndrome (ARDS), acute respiratory failure, atelectasis requiring intervention, bronchopleural fistula, empyema thoracis, hemothorax, pneumonia, stroke or venous thromboembolism

Minor complication rate

perioperative period (within 30 days after anatomic lung resection)

proportion of patients who develop atrial fibrillation, pneumothorax or prolonged air leak

Length of postoperative hospital stay

perioperative period (up to 30 days after anatomic lung resection)

time duration from surgery to discharge order

Eligibility

Sex

all

Healthy Volunteers

Yes

View full criteria

Inclusion Criteria:

* underwent anatomic lung resection
* previous COVID-19 infection documented by nasopharyngeal swab RT-PCR or GeneXpert
* with negative nasopharyngeal swab RT-PCR or GeneXpert prior to lung resection

Exclusion Criteria:

* with incomplete patient records

Ask AI

Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)